Suppr超能文献

三模式治疗后食管癌患者手术标本中恶性淋巴结高概率相关的列线图。

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

机构信息

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.

出版信息

Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.

Abstract

BACKGROUND

The presence of malignant lymph nodes (+ypNodes) in the surgical specimen after preoperative chemoradiation (trimodality) in patients with oesophageal cancer (EC) portends a poor prognosis for overall survival (OS) and disease-free survival (DFS). Currently, none of the clinical variables highly correlates with +ypNodes. We hypothesised that a combination of clinical variables could generate a model that associates with high likelihood of +ypNodes after trimodality in EC patients.

METHODS

We report on 293 consecutive EC patients who received trimodality therapy. A multivariate logistic regression analysis that included pretreatment and post-chemoradiation variables identified independent variables that were used to construct a nomogram for +ypNodes after trimodality in EC patients.

RESULTS

Of 293 patients, 91 (31.1%) had +ypNodes. OS (p=0.0002) and DFS (p<0.0001) were shorter in patients with +ypNodes compared to those with -ypNodes. In multivariable analysis, the significant variables for +ypNodes were: baseline T-stage (odds ratio [OR], 7.145; 95% confidence interval [CI], 1.381-36.969; p=0.019), baseline N-stage (OR, 2.246; 95% CI, 1.024-4.926; p=0.044), tumour length (OR, 1.178; 95% CI, 1.024-1.357; p=0.022), induction chemotherapy (OR, 0.471; 95% CI, 0.242-0.915; p=0.026), nodal uptake on post-chemoradiation positron emission tomography (OR, 2.923; 95% CI, 1.007-8.485; p=0.049) and enlarged node(s) on post-chemoradiation computerised tomography (OR, 3.465; 95% CI, 1.549-7.753; p=0.002). The nomogram after internal validation using the bootstrap method (200 runs) yielded a high concordance index of 0.756.

CONCLUSION

Our nomogram highly correlates with the presence of +ypNodes after chemoradiation, however, considerably more refinement is needed before it can be implemented in the clinic.

摘要

背景

在接受术前放化疗(三联疗法)的食管癌患者的手术标本中存在恶性淋巴结(+ypNodes),预示着总生存(OS)和无病生存(DFS)的预后不良。目前,没有任何临床变量与+ypNodes 高度相关。我们假设,临床变量的组合可以生成一个模型,该模型与三联疗法后食管癌患者发生+ypNodes 的可能性高度相关。

方法

我们报告了 293 例连续接受三联疗法的食管癌患者。多变量逻辑回归分析包括预处理和放化疗后变量,确定了独立变量,用于构建三联疗法后食管癌患者+ypNodes 的列线图。

结果

在 293 例患者中,91 例(31.1%)存在+ypNodes。与-ypNodes 相比,+ypNodes 患者的 OS(p=0.0002)和 DFS(p<0.0001)更短。多变量分析中,+ypNodes 的显著变量为:基线 T 期(优势比[OR],7.145;95%置信区间[CI],1.381-36.969;p=0.019)、基线 N 期(OR,2.246;95%CI,1.024-4.926;p=0.044)、肿瘤长度(OR,1.178;95%CI,1.024-1.357;p=0.022)、诱导化疗(OR,0.471;95%CI,0.242-0.915;p=0.026)、放化疗后正电子发射断层扫描(PET)的淋巴结摄取(OR,2.923;95%CI,1.007-8.485;p=0.049)和放化疗后计算机断层扫描(CT)的肿大淋巴结(OR,3.465;95%CI,1.549-7.753;p=0.002)。内部验证使用自举法(200 次运行)后生成的列线图具有 0.756 的高一致性指数。

结论

我们的列线图与放化疗后+ypNodes 的存在高度相关,但在临床应用之前还需要进一步细化。

相似文献

2
Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.
J Surg Oncol. 2021 Mar;123(4):881-890. doi: 10.1002/jso.26349. Epub 2020 Dec 17.
4
Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Ann Surg Oncol. 2013 Sep;20(9):3038-43. doi: 10.1245/s10434-013-2988-4. Epub 2013 Apr 28.
5
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Ann Surg Oncol. 2018 Jun;25(6):1598-1607. doi: 10.1245/s10434-018-6435-4. Epub 2018 Mar 22.
7
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
World J Gastroenterol. 2013 Dec 28;19(48):9282-93. doi: 10.3748/wjg.v19.i48.9282.
10
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.

引用本文的文献

1
Development of a Nomogram to Predict the Outcome for Patients with Soft Tissue Sarcoma.
Vet Sci. 2023 Mar 29;10(4):266. doi: 10.3390/vetsci10040266.
2
A Novel RNA-Seq-Based Model for Preoperative Prediction of Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Biomed Res Int. 2020 Aug 31;2020:4252580. doi: 10.1155/2020/4252580. eCollection 2020.
5
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using F-FDG PET/CT.
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1742-1751. doi: 10.1007/s00259-018-4011-6. Epub 2018 Apr 16.
7
Nomograms in oncology: more than meets the eye.
Lancet Oncol. 2015 Apr;16(4):e173-80. doi: 10.1016/S1470-2045(14)71116-7.

本文引用的文献

1
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
3
A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.
Ann Surg. 2010 Oct;252(4):611-7. doi: 10.1097/SLA.0b013e3181f56419.
4
Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
Ann Surg Oncol. 2011 Feb;18(2):551-8. doi: 10.1245/s10434-010-1314-7. Epub 2010 Sep 14.
6
Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Ann Surg Oncol. 2010 Dec;17(12):3187-94. doi: 10.1245/s10434-010-1196-8. Epub 2010 Jun 29.
7
Optimum lymphadenectomy for esophageal cancer.
Ann Surg. 2010 Jan;251(1):46-50. doi: 10.1097/SLA.0b013e3181b2f6ee.
10
Worldwide esophageal cancer collaboration.
Dis Esophagus. 2009;22(1):1-8. doi: 10.1111/j.1442-2050.2008.00901.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验